Skip to main content
Top
Published in: Supportive Care in Cancer 2/2014

01-02-2014 | Original Article

Predictors of anxiety and depression in people with colorectal cancer

Authors: Nicola M. Gray, Susan J. Hall, Susan Browne, Marie Johnston, Amanda J. Lee, Una Macleod, Elizabeth D. Mitchell, Leslie Samuel, Neil C. Campbell

Published in: Supportive Care in Cancer | Issue 2/2014

Login to get access

Abstract

Background

People living with colorectal cancer are at risk of anxiety and depression. We investigated what factors were most highly associated with these.

Methods

Four hundred and ninety-six people with colorectal cancer completed the Hospital Anxiety and Depression Scale (HADS). Data on functioning, symptoms, illness perceptions and social difficulties were collected by questionnaire. Case-note-identified disease, treatment and co-morbidity data were recorded. Multiple logistic regression identified factors independently predictive of anxiety and depression caseness.

Results

Self-reported history of anxiety/depression predicted anxiety but not depression caseness. Depression caseness predicted anxiety caseness (p = 0.043), as did poorer self-reported cognitive functioning (p = 0.001), dyspnoea (p = 0.015) or diarrhoea (p = 0.021), reporting a high negative life and emotional impact (p < 0.001) and having difficulties with finance (p = 0.007). Having neo-adjuvant radiotherapy increased the odds of depression caseness (p = 0.007), as did poorer physical (p = 0.007), cognitive (p < 0.001) and social (p < 0.001) functioning, having constipation (p = 0.011), reporting a high negative life and emotional impact (p < 0.001), having difficulties with personal care (p = 0.022) and communicating with others (p = 0.014).

Conclusion

Levels of anxiety caseness were similar to those of non-clinical samples, but depression caseness was higher, particularly in those who had received neo-adjuvant radiotherapy. Most factors associated with possible or probable depression may be modified with appropriate intervention.
Appendix
Available only for authorised users
Literature
3.
go back to reference Elliott J, Fallows A, Staetsky L, Smith PW, Foster CL, Maher EJ, Corner J (2011) The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer 105(Suppl 1):11–20. doi:10.1038/bjc.2011.418 CrossRef Elliott J, Fallows A, Staetsky L, Smith PW, Foster CL, Maher EJ, Corner J (2011) The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer 105(Suppl 1):11–20. doi:10.​1038/​bjc.​2011.​418 CrossRef
4.
go back to reference Department of Health (2012) Quality of life of cancer survivors in England. Report on a pilot survey using Patient Reported Outcome Measures (PROMS). National Institute for Health Research, London Department of Health (2012) Quality of life of cancer survivors in England. Report on a pilot survey using Patient Reported Outcome Measures (PROMS). National Institute for Health Research, London
5.
go back to reference Scottish Intercollegiate Guideline Network (SIGN) (2011) Diagnosis and management of colorectal cancer. Guideline number 126. SIGN, Edinburgh Scottish Intercollegiate Guideline Network (SIGN) (2011) Diagnosis and management of colorectal cancer. Guideline number 126. SIGN, Edinburgh
7.
9.
go back to reference Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef
10.
go back to reference Tsunoda A, Nakao K, Hiratsuka K, Yasuda N, Shibusawa M, Kusano M (2005) Anxiety, depression and quality of life in colorectal cancer patients. Int J Clin Oncol 10:411–417PubMedCrossRef Tsunoda A, Nakao K, Hiratsuka K, Yasuda N, Shibusawa M, Kusano M (2005) Anxiety, depression and quality of life in colorectal cancer patients. Int J Clin Oncol 10:411–417PubMedCrossRef
14.
go back to reference Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR (2002) Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 97:1228–1234PubMedCrossRef Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR (2002) Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 97:1228–1234PubMedCrossRef
16.
go back to reference Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54:269–282PubMedCrossRef Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54:269–282PubMedCrossRef
18.
go back to reference Salvo N et al (2012) Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer. Clin Oncol 24:139e–148eCrossRef Salvo N et al (2012) Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer. Clin Oncol 24:139e–148eCrossRef
19.
go back to reference Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C (2011) Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer 105:1814–1817PubMedCentralPubMedCrossRef Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C (2011) Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer 105:1814–1817PubMedCentralPubMedCrossRef
20.
go back to reference Rhondali W, Perceau E, Berthiller J, Saltel P, Trillet-Lenoir V, Tredan O, Coulon JP, Bruera E, Filbet M (2012) Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer 20:2795–2802. doi:10.1007/s00520-012-1401-3 PubMedCrossRef Rhondali W, Perceau E, Berthiller J, Saltel P, Trillet-Lenoir V, Tredan O, Coulon JP, Bruera E, Filbet M (2012) Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer 20:2795–2802. doi:10.​1007/​s00520-012-1401-3 PubMedCrossRef
22.
go back to reference Pereira MG, Figueiredo AP, Fincham FD (2012) Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: a study with Portuguese patients and their partners. Eur J Oncol Nurs 16:227e–232eCrossRef Pereira MG, Figueiredo AP, Fincham FD (2012) Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: a study with Portuguese patients and their partners. Eur J Oncol Nurs 16:227e–232eCrossRef
23.
go back to reference Bang S, Park SH, Kang HG, Jue JI, Cho IH, Yun YH, Cho EK, Shin DB, Lee JH (2005) Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 13:515–521PubMedCrossRef Bang S, Park SH, Kang HG, Jue JI, Cho IH, Yun YH, Cho EK, Shin DB, Lee JH (2005) Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 13:515–521PubMedCrossRef
24.
go back to reference Hodges K, Winstanley S (2012) Effects of optimism, social support, fighting spirit, cancer worry and internal health locus of control on positive affect in cancer survivors: a path analysis. Stress Heal 28:408–415. doi:10.1002/smi.2471 CrossRef Hodges K, Winstanley S (2012) Effects of optimism, social support, fighting spirit, cancer worry and internal health locus of control on positive affect in cancer survivors: a path analysis. Stress Heal 28:408–415. doi:10.​1002/​smi.​2471 CrossRef
25.
go back to reference Husson O, Thong MS, Mols F, Oerlemans S, Kaptein AA, van de Poll-Franse LV (2013) Illness perceptions in cancer survivors: what is the role of information provision? Psycho-Oncology 22(3):490–498PubMedCrossRef Husson O, Thong MS, Mols F, Oerlemans S, Kaptein AA, van de Poll-Franse LV (2013) Illness perceptions in cancer survivors: what is the role of information provision? Psycho-Oncology 22(3):490–498PubMedCrossRef
28.
go back to reference Groenvold M, Klee MC, Sprangers MAG, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441–450PubMedCrossRef Groenvold M, Klee MC, Sprangers MAG, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441–450PubMedCrossRef
30.
go back to reference Wright P, Smith A, Roberts K, Selby P, Velikova G (2007) Screening for social difficulties in cancer patients: clinical utility of the social difficulties inventory. Br J Cancer 97:1063–1070PubMedCentralPubMedCrossRef Wright P, Smith A, Roberts K, Selby P, Velikova G (2007) Screening for social difficulties in cancer patients: clinical utility of the social difficulties inventory. Br J Cancer 97:1063–1070PubMedCentralPubMedCrossRef
31.
32.
go back to reference Crawford JR, Henry JD, Crombie C, Taylor EP (2001) Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 40:429–434PubMedCrossRef Crawford JR, Henry JD, Crombie C, Taylor EP (2001) Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 40:429–434PubMedCrossRef
33.
Metadata
Title
Predictors of anxiety and depression in people with colorectal cancer
Authors
Nicola M. Gray
Susan J. Hall
Susan Browne
Marie Johnston
Amanda J. Lee
Una Macleod
Elizabeth D. Mitchell
Leslie Samuel
Neil C. Campbell
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1963-8

Other articles of this Issue 2/2014

Supportive Care in Cancer 2/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine